Showing 1 - 6 results of 6 for search 'Bernd Wullich', query time: 0.02s Refine Results
  1. 1
    Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis.

    Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis. by Danijel Sikic, Bastian Keck, Sven Wach, Helge Taubert, Bernd Wullich, Peter J Goebell, Andreas Kahlmeyer, Peter Olbert, Philipp Isfort, Wilhelm Nimphius, Arndt Hartmann, Johannes Giedl, Bridge Consortium

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer

    Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer by Maximilian Haas, Roman Mayr, Danijel Sikic, Bernd Wullich, Niklas Klümper, Philipp Erben, Ralph Wirtz, Christian Bolenz, Florian Roghmann, Robert Stöhr, Veronika Bahlinger, Arndt Hartmann, Maximilian Burger, Johannes Breyer, Markus Eckstein

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer

    AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer by Pierre-Antoine Bannier, Charlie Saillard, Philipp Mann, Maxime Touzot, Charles Maussion, Christian Matek, Niklas Klümper, Johannes Breyer, Ralph Wirtz, Danijel Sikic, Bernd Schmitz-Dräger, Bernd Wullich, Arndt Hartmann, Sebastian Försch, Markus Eckstein

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer

    The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer by Juan Guzman, Martin Hart, Katrin Weigelt, Angela Neumann, Achim Aigner, Chiara Andolfi, Florian Handle, Stefanie Rheinheimer, Ulrike Fischer, Uta D. Immel, Verena Lieb, Eckart Meese, Zoran Culig, Bernd Wullich, Helge Taubert, Sven Wach

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma

    PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma by Niklas Klümper, Lennert Wüst, Jonas Saal, Damian J. Ralser, Romina Zarbl, Jonas Jarczyk, Johannes Breyer, Danijel Sikic, Bernd Wullich, Christian Bolenz, Florian Roghmann, Michael Hölzel, Manuel Ritter, Sebastian Strieth, Arndt Hartmann, Philipp Erben, Ralph M. Wirtz, Jennifer Landsberg, Dimo Dietrich, Markus Eckstein

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy

    Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemothera... by Arndt Hartmann, Bernd Wullich, Markus Eckstein, Pamela Strissel, Reiner Strick, Veronika Weyerer, Ralph Wirtz, Carolin Pfannstiel, Adrian Wullweber, Fabienne Lange, Philipp Erben, Robert Stoehr, Simone Bertz, Carol Imanuel Geppert, Nicole Fuhrich, Helge Taubert, Sven Wach, Johannes Breyer, Wolfgang Otto, Maximilian Burger, Christian Bolenz, Bastian Keck, Danijel Sikic

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: